GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Cyclically Adjusted PS Ratio

DexCom (XTER:DC4) Cyclically Adjusted PS Ratio : 27.43 (As of May. 24, 2024)


View and export this data going back to 1990. Start your Free Trial

What is DexCom Cyclically Adjusted PS Ratio?

As of today (2024-05-24), DexCom's current share price is €119.60. DexCom's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €4.36. DexCom's Cyclically Adjusted PS Ratio for today is 27.43.

The historical rank and industry rank for DexCom's Cyclically Adjusted PS Ratio or its related term are showing as below:

XTER:DC4' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 15.47   Med: 35.61   Max: 71.43
Current: 27.99

During the past years, DexCom's highest Cyclically Adjusted PS Ratio was 71.43. The lowest was 15.47. And the median was 35.61.

XTER:DC4's Cyclically Adjusted PS Ratio is ranked worse than
96.84% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs XTER:DC4: 27.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DexCom's adjusted revenue per share data for the three months ended in Mar. 2024 was €2.033. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €4.36 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DexCom Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DexCom's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Cyclically Adjusted PS Ratio Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.73 46.71 50.32 32.52 28.31

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.36 32.70 22.36 28.31 29.74

Competitive Comparison of DexCom's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, DexCom's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DexCom's Cyclically Adjusted PS Ratio falls into.



DexCom Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DexCom's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=119.60/4.36
=27.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DexCom's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.033/131.7762*131.7762
=2.033

Current CPI (Mar. 2024) = 131.7762.

DexCom Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.144 100.560 0.189
201409 0.176 100.428 0.231
201412 0.223 99.070 0.297
201503 0.216 99.621 0.286
201506 0.261 100.684 0.342
201509 0.291 100.392 0.382
201512 0.368 99.792 0.486
201603 0.318 100.470 0.417
201606 0.365 101.688 0.473
201609 0.394 101.861 0.510
201612 0.480 101.863 0.621
201703 0.390 102.862 0.500
201706 0.434 103.349 0.553
201709 0.447 104.136 0.566
201712 0.537 104.011 0.680
201803 0.428 105.290 0.536
201806 0.580 106.317 0.719
201809 0.633 106.507 0.783
201812 0.836 105.998 1.039
201903 0.687 107.251 0.844
201906 0.817 108.070 0.996
201909 0.973 108.329 1.184
201912 1.125 108.420 1.367
202003 0.974 108.902 1.179
202006 1.034 108.767 1.253
202009 1.069 109.815 1.283
202012 1.177 109.897 1.411
202103 1.014 111.754 1.196
202106 1.156 114.631 1.329
202109 1.284 115.734 1.462
202112 1.432 117.630 1.604
202203 1.332 121.301 1.447
202206 1.563 125.017 1.648
202209 1.825 125.227 1.920
202212 1.806 125.222 1.901
202303 1.655 127.348 1.713
202306 1.864 128.729 1.908
202309 2.141 129.860 2.173
202312 2.274 129.419 2.315
202403 2.033 131.776 2.033

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DexCom  (XTER:DC4) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DexCom Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DexCom's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (XTER:DC4) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (XTER:DC4) Headlines

No Headlines